为展示和传播药学领域的多学科学术研究,我们为您推荐 Taylor & Francis Group 旗下的优质综合国际期刊,我们期待您最新的研究成果能够通过高水平期刊在科研界得到广泛传播,为推进科学发展做出贡献,您亦可登录期刊官网(www.tandfonline.com)查阅全部期刊及文章。若您正在为目前的研究寻找一个合适的发表杂志,请使用 Call for Papers 及 Journal Suggester 查询适合您的期刊选择!

Taylor & Francis药学领域重点期刊推荐

Description: A MEDLINE-indexed journal primarily publishing Reviews, Original Research, Editorials and Perspectives. The emphasis is on drugs or drug classes in early stage clinical trials and preclinical development and their potential impact on future treatment strategies. This journal offers accelerated publication.

Citation Metrics

Impact Factor: Impact Factor
2024 IF: 4.1
Impact Factor Best Quartile: Impact Factor Best Quartile
IF Best Quartile: Q1
5 year IF: 5 year IF
2024 5 Year IF: 4.4
CiteScore: CiteScore
CiteScore: 8.3
CiteScore Best Quartile: CiteScore Best Quartile
CiteScore Best Quartile: Q1

Speed/Acceptance

Speed from submission to first decision (days): Speed from submission to first decision
Speed From Submission To First Decision (median): 2
View Expert Opinion on Investigational Drugs
Description: Publishes open access research on oral, pulmonary, nasal, parental and transdermal drug delivery systems and conjugates, and drug entry and targeting.

Citation Metrics

Impact Factor: Impact Factor
2024 IF: 8.1
Impact Factor Best Quartile: Impact Factor Best Quartile
IF Best Quartile: Q1
5 year IF: 5 year IF
2024 5 Year IF: 7.5
CiteScore: CiteScore
CiteScore: 16.4
CiteScore Best Quartile: CiteScore Best Quartile
CiteScore Best Quartile: Q1

Speed/Acceptance

Speed from submission to first decision (days): Speed from submission to first decision
Speed From Submission To First Decision (median):
View Drug Delivery
Description: A MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. It offers accelerated publication.

Citation Metrics

Impact Factor: Impact Factor
2024 IF: 4.9
Impact Factor Best Quartile: Impact Factor Best Quartile
IF Best Quartile: Q1
5 year IF: 5 year IF
2024 5 Year IF: 6.3
CiteScore: CiteScore
CiteScore: 10.6
CiteScore Best Quartile: CiteScore Best Quartile
CiteScore Best Quartile: Q1

Speed/Acceptance

Speed from submission to first decision (days): Speed from submission to first decision
Speed From Submission To First Decision (median): 1
View Expert Opinion on Drug Discovery
Description: Publishes open access research on natural medicines, biologically active natural products or their derivatives, and complex traditional medicine formulas.

Citation Metrics

Impact Factor: Impact Factor
2024 IF: 4.8
Impact Factor Best Quartile: Impact Factor Best Quartile
IF Best Quartile: Q1
5 year IF: 5 year IF
2024 5 Year IF: 4.4
CiteScore: CiteScore
CiteScore: 9.2
CiteScore Best Quartile: CiteScore Best Quartile
CiteScore Best Quartile: Q1

Speed/Acceptance

Speed from submission to first decision (days): Speed from submission to first decision
Speed From Submission To First Decision (median):
View Pharmaceutical Biology

推荐期刊列表

了解更多药学及其他各学科高水平国际期刊,请访问 Taylor & Francis Group 旗下学术期刊网站, 欢迎相关学科研究人员向您青睐的杂志投稿。

期刊网站:www.tandfonline.com

立即投稿

Taylor & Francis 编辑润色服务

在准备向期刊提交稿件的时候,您需要协助吗? Taylor & Francis 编辑润色服务提供包括英语语言编辑、科学润色、翻译加编辑、稿件格式调整、相似度检查以及技术审核等,让您将时间集中在研究上。

为期刊、图书作者提供的实用指南

在您准备撰写一篇国际学术论文时,一个为您提供必要指导和资源实用网站可以为您解答许多疑问!从选刊、写作、投稿、同行评审、出版等各个方面给予详细的指导,写作投稿前的必看网站!

拥抱开放科学

开放获取对于作者、读者而言极具价值,开放科学让研究在更广泛的维度得到参考和使用,提升研究可见度和影响力,造福社会。您是否考虑发表开放获取文章?点击了解开放获取出版更多信息